In summary, our purpose is to find reliable biomarkers related to the prognosis of GBM by analyzing the relationship between DARS/GDI2/P4HA2/TRUB1 gene and GBM, so as to provide reference and basis for clinical treatment and prognosis observation of GBM. This evidence concerns the gene DARS1 and glioblastoma.